当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:158.04亿  总市值:158.04亿
流通股本:11.80亿   总股本:11.80亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,865,923,880.94,771,642,915.882,824,279,976.5511,160,388,744.46
  收到的税费返还37,739,287.3427,088,126.53,576,747.6112,275,558.1
  收到其他与经营活动有关的现金208,852,590.48132,105,762.4759,956,036.49356,429,834.69
  经营活动现金流入小计7,112,515,758.724,930,836,804.852,887,812,760.6511,529,094,137.25
  购买商品、接受劳务支付的现金2,016,900,268.861,378,456,246.64973,099,597.525,131,740,533.08
  支付给职工以及为职工支付的现金1,542,073,967.631,083,683,246.46659,366,208.671,785,937,977.63
  支付的各项税费828,790,883.09615,911,361.57286,099,226.5817,826,210.59
  支付其他与经营活动有关的现金1,519,236,886.991,020,751,549.78518,419,818.351,761,913,400.53
  经营活动现金流出小计5,907,002,006.574,098,802,404.452,436,984,851.049,497,418,121.83
  经营活动产生的现金流量净额1,205,513,752.15832,034,400.4450,827,909.612,031,676,015.42
二、投资活动产生的现金流量:
  收回投资收到的现金47,956,275.754,250,0004,250,000-
  取得投资收益收到的现金2,105,439.66150,000-11,544,400
  处置固定资产、无形资产和其他长期资产收回的现金净额2,610,342.491,418,869.02313,575.4214,677,947.53
  处置子公司及其他营业单位收到的现金净额465,311,216.41465,311,216.41465,311,216.41-
  收到的其他与投资活动有关的现金4,717,791.732,957,618.931,054,00560,017,100
  投资活动现金流入小计522,701,066.04474,087,704.36470,928,796.8386,239,447.53
  购建固定资产、无形资产和其他长期资产支付的现金342,278,809.2217,979,274.31127,735,066.71376,395,257.64
  投资支付的现金402,500,000402,500,000-78,284,936.65
  支付其他与投资活动有关的现金135,214,630.8139,088,064.8138,367,752.87660,000
  投资活动现金流出小计879,993,440759,567,339.11266,102,819.58455,340,194.29
  投资活动产生的现金流量净额-357,292,373.96-285,479,634.75204,825,977.25-369,100,746.76
三、筹资活动产生的现金流量:
  吸收投资收到的现金10,800,00010,800,000--
  其中:子公司吸收少数股东投资收到的现金10,800,00010,800,000--
  取得借款收到的现金1,039,000,000881,000,000741,000,0002,357,854,777.04
  筹资活动现金流入小计1,049,800,000891,800,000741,000,0002,357,854,777.04
  偿还债务支付的现金1,716,834,7301,333,978,730767,178,7303,558,356,912.96
  分配股利、利润或偿付利息支付的现金279,948,853.31269,730,296.1114,605,856.13343,424,482.78
  支付其他与筹资活动有关的现金52,646,982.3641,249,099.9435,892,040.1989,461,043.42
  筹资活动现金流出小计2,049,430,565.671,644,958,126.05817,676,626.323,991,242,439.16
  筹资活动产生的现金流量净额-999,630,565.67-753,158,126.05-76,676,626.32-1,633,387,662.12
四、汇率变动对现金及现金等价物的影响-5,385,824.27-3,846,826.12-1,508,819.97-887,015.79
五、现金及现金等价物净增加额-156,795,011.75-210,450,186.52577,468,440.5728,300,590.75
  加:期初现金及现金等价物余额1,218,184,997.461,218,184,997.461,218,184,997.461,189,884,406.71
  期末现金及现金等价物余额1,061,389,985.711,007,734,810.941,795,653,438.031,218,184,997.46
补充资料:
  净利润-641,713,626.28-547,485,702.43
  资产减值准备-79,751,159.13-213,171,765.88
  固定资产和投资性房地产折旧-406,626,030.32-839,605,626.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-406,626,030.32-839,605,626.49
  无形资产摊销-52,681,111.72-119,836,009.25
  长期待摊费用摊销-1,713,998.8-2,950,260.29
  处置固定资产、无形资产和其他长期资产的损失--849,833.5--5,234,365.98
  固定资产报废损失-3,279,204.99-2,619,979.32
  公允价值变动损失-1,161,748.71-34,782,686.47
  财务费用-36,549,017.53-102,918,776.73
  投资损失--176,467,593.72-34,724,323.36
  递延所得税-20,245,299.72-28,719,719.04
  其中:递延所得税资产减少-20,429,928.23-28,898,364.59
    递延所得税负债增加--184,628.51--178,645.55
  存货的减少-318,878,634.58-66,089,346.39
  经营性应收项目的减少--210,613,710.36-33,090,521.08
  经营性应付项目的增加--366,251,194.05--59,352,548.42
  其他-108,965.96-512,982.57
  现金的期末余额-1,007,734,810.94-1,218,184,997.46
  减:现金的期初余额-1,218,184,997.46-1,189,884,406.71
  现金及现金等价物的净增加额--210,450,186.52-28,300,590.75
公告日期2026-10-282026-08-262026-04-282026-04-08
审计意见(境内)标准无保留意见
TOP↑